This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Vedanta Biosciences, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Bruce Roberts: Innovator in Microbiome Research
Introduction
Bruce Roberts is a notable inventor based in Sudbury, MA (US), recognized for his contributions to the field of microbiome research. With a total of three patents to his name, he has made significant strides in developing methods that address dysbiosis and allergies.
Latest Patents
One of Bruce Roberts' latest patents focuses on methods of decreasing dysbiosis and restoring a microbiome. This patent outlines pharmaceutical compositions that can be administered to subjects to restore a healthy microbiome, particularly following events that induce dysbiosis. Another important patent involves compositions and methods for treating allergies, including food allergies. This innovation aims to modulate immune responses associated with allergies and promote immune tolerance or desensitization.
Career Highlights
Bruce Roberts is currently associated with Vedanta Biosciences, Inc., where he applies his expertise in microbiome research. His work is pivotal in advancing our understanding of how to maintain and restore healthy microbiomes in individuals.
Collaborations
Throughout his career, Bruce has collaborated with notable colleagues, including Bernat Olle and Rose L Szabady, contributing to a dynamic research environment that fosters innovation.
Conclusion
In summary, Bruce Roberts is a distinguished inventor whose work in microbiome research has led to significant advancements in treating dysbiosis and allergies. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
